| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 72.325 | 153.764 | 195.658 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 72.329 | 153.773 | 195.677 |
| Total Expenses - EUR | - | - | - | - | - | - | 0 | 29.076 | 52.790 | 51.896 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 0 | 43.253 | 100.983 | 143.781 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 0 | 42.962 | 99.445 | 137.910 |
| Employees | - | - | - | - | - | - | 0 | 3 | 3 | 3 |
Check the financial reports for the company - Deomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 4.176 | 3.940 | 2.623 |
| Current Assets | - | - | - | - | - | - | 40 | 42.681 | 100.189 | 140.912 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 97 |
| Receivables | - | - | - | - | - | - | 0 | 23.847 | 76.787 | 134.644 |
| Cash | - | - | - | - | - | - | 40 | 18.833 | 23.402 | 6.171 |
| Shareholders Funds | - | - | - | - | - | - | 40 | 42.964 | 99.448 | 137.913 |
| Social Capital | - | - | - | - | - | - | 40 | 2 | 2 | 2 |
| Debts | - | - | - | - | - | - | 0 | 3.892 | 4.681 | 5.622 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Deomed S.r.l.